U.S. Retail REITs Stock News

O'Reilly Automotive, Inc. has appointed Colin Yankee, a veteran retail supply chain leader with more than 20 years’ experience at Tractor Supply Company, Neiman Marcus, and Target, as Executive Vice President and Chief Supply Chain Officer, effective July 13, 2026. This hire puts a seasoned operator in charge of merchandise, inventory management, distribution, and transportation, directly connecting leadership strength to one of O’Reilly’s core competitive capabilities. We’ll now examine how...

Primerica (PRI) has drawn investor attention after recent trading left the stock at a last close of US$310.54. Its current valuation and business mix are in focus rather than any single headline event. See our latest analysis for Primerica. Recent trading has been relatively firm, with a 30 day share price return of 10.21% and a year to date share price return of 20.02%. The 5 year total shareholder return of 130.16% points to steadily compounding gains over a longer horizon. If Primerica's...

Younger workers are rewriting the rules of work, trading corporate ladders for seasonal jobs, flexible gigs, and lifestyle-focused roles that often come with lower pay but cheaper living costs and more free time. That shift can reshape where money is earned, saved, and spent, especially on travel, experiences, and services tied to flexible living. This article looks at how that news-driven trend connects to the stock market and highlights 3 stocks from the Stocks Shaped by Shifts in Worker...

In July 2026, Chesapeake Utilities Corporation and its subsidiary Peninsula Pipeline Company announced the Florida Energy Pathway, a new 24-inch intrastate natural gas pipeline running from Palm Beach County to Miami-Dade County, backed by nearly 250,000 dekatherms per day of firm shipper commitments and an estimated US$1.20 billion project cost. The project’s planned 2030 in-service date, long-term investment-grade shipper contracts and intention to bring in partners for up to 49% ownership...

Glacier Bancorp (GBCI) is back on investors’ radar after recent trading, with the stock closing at US$53.57 and showing mixed short term moves, including a 1.7% decline over the past day. See our latest analysis for Glacier Bancorp. While Glacier Bancorp’s share price slipped 1.7% over the last day, the 7 day share price return of 4.0% and year to date share price return of 20.0% sit alongside a 1 year total shareholder return of 20.5%, hinting that momentum has been building rather than...

Safehold (SAFE) is back in focus after closing two ground leases in California that support 570 affordable housing units, bringing fresh attention to how the stock reflects this expanding ground lease pipeline. See our latest analysis for Safehold. Against this backdrop of new affordable housing ground leases, Safehold's recent 7 day share price return of 6.15% and year to date share price return of 25.46% contrast with a 5 year total shareholder return that is down 77.01%. This suggests...

Event driven move in Revolution Medicines stock Revolution Medicines (RVMD) is back in focus after positive Phase III results for its lead drug, Daraxonrasib, in metastatic pancreatic cancer and new FDA designations that could streamline the regulatory timeline. The FDA granted Daraxonrasib both Breakthrough Therapy and Orphan Drug status, and the company is preparing a New Drug Application while advancing several late stage trials, developments investors are watching closely. See our latest...

ANI Pharmaceuticals recently reported positive topline results from its Phase 4 SYNCHRONICITY trial of the fluocinolone acetonide intravitreal implant in U.S. patients with chronic non-infectious uveitis affecting the posterior segment, with both co-primary endpoints in visual acuity and central subfield thickness met at six months. The data add real-world support for ILUVIEN’s expanded indication in chronic NIU-PS, potentially reinforcing its role in retina specialists’ treatment decisions...

Cintas Corporation reported past fourth-quarter and full-year 2026 results, with sales rising to US$2,197.71 million and US$8,621.62 million respectively, alongside higher net income and earnings per share from continuing operations. The company also disclosed full-year revenue of US$11.26 billion and issued fiscal 2027 revenue guidance of US$12.10–US$12.25 billion, highlighting continued demand across its uniform and business services offerings. With Cintas pairing higher full-year earnings...

US small business financials sit at an interesting crossroads, with a modest rate hike expected, steady credit conditions, and consumers still spending. For investors, that mix can influence how regional banks and specialty lenders manage risk, grow their loan books, and support Main Street clients. This article looks at how the latest macro signals link back to companies in our US Small Business Financials screener and how that might affect their risk and opportunity profile. Ahead, you will...

Rockwell Automation (ROK) heads into an anticipated earnings update with attention on fresh client wins, including its role in Aalo Atomics' Aalo-X test reactor and Hadaf Foods' Plex-enabled manufacturing upgrade. See our latest analysis for Rockwell Automation. Recent announcements such as the Aalo-X test reactor and Hadaf Foods wins come as Rockwell Automation’s share price sits at $461.85. Short term momentum has eased, but a 90-day share price return of 11.64% and a 1-year total...

Samsung’s decision to cut U.S. jobs and double down on its chip division is a clear reminder that capital can move quickly toward what management sees as its strongest profit engines. For investors, it raises the question of which semiconductor and chip stocks might benefit as resources shift toward AI-focused production and infrastructure, and which could face pressure as consumer electronics take a back seat. This article breaks down three stocks from our AI Semiconductor and Chip Makers...

PTC Therapeutics (PTCT) is back in focus after its PTC518 Huntington’s disease program received Fast Track designation, a regulatory milestone that can influence how investors view its rare neurology pipeline. See our latest analysis for PTC Therapeutics. At a share price of $78.59, PTC Therapeutics has a 90 day share price return of 8.67%, while its 1 year total shareholder return of 65% suggests stronger momentum over a longer window despite recent short term weakness. The Fast Track news...

Murphy USA Stock Snapshot After Recent Performance Murphy USA (MUSA) has drawn fresh attention after a strong recent run, with the stock up around 12% over the past month and about 25% over the past 3 months. See our latest analysis for Murphy USA. At a share price of $618.57, Murphy USA’s recent 1-day share price return of 3.27% and year to date share price return of 52.61% sit alongside a 1-year total shareholder return of 47.80% and 5-year total shareholder return of 341.46%. This points...

In recent trading, Albemarle’s shares closed at US$120.78 after a 1.1% daily gain, as investors looked back on its August 5, 2026 earnings release that had been closely anticipated. The key development was a wave of upward earnings estimate revisions and an improved Zacks Rank of #2 (Buy), signaling a meaningful shift in analyst confidence around Albemarle’s near-term business trends. We’ll now examine how these higher earnings expectations and the stronger Zacks Rank might influence...

Willis Lease Finance (WLFC) has attracted fresh attention after its recent share price pullback, with the stock down 7.2% over the past month and 5.7% over the past 3 months. See our latest analysis for Willis Lease Finance. Short term momentum for Willis Lease Finance has cooled, with the share price down 13.3% over the past week, 7.2% over the past month, and 5.7% over the past quarter, even as the year to date share price return of 42.9% and very large multi year total shareholder returns...

Concentra Group Holdings Parent recently opened a new medical center near Kansas City International Airport in Missouri, expanding access to occupational medicine, injury care, regulatory exams, and telemedicine-supported services for employers in a major Midwestern business and transportation hub. This expansion strengthens Concentra’s integrated network model by pairing on-site clinical capabilities with its Concentra Telemed platform, potentially enhancing employer convenience and...

In recent trading, First Bancorp (FBNC) saw a surge in options activity, with August 21, 2026 $70 call contracts exhibiting unusually high implied volatility and pointing to heightened speculation around the stock. This options-driven interest, combined with First Bancorp’s price-to-earnings ratio of 22.1x versus the broader US Banks industry, highlights how investors may be assigning a premium to its earnings profile despite mixed valuation signals. We’ll now examine how this spike in...

Recently, concerns surfaced after Intuitive Surgical cautioned that changes to certain U.S. insurance plans could slow procedure volumes, prompting a broad reassessment of demand for medical devices, including those made by Globus Medical. This development highlights how even indirect policy shifts in reimbursement can quickly ripple through procedure-dependent industries, challenging expectations for companies built around growing surgical technology adoption. Next, we’ll examine how...

In recent days, Mach Natural Resources has attracted increasingly positive analyst attention, including a Strong Buy consensus rating and fresh Buy recommendations from firms such as William Blair. This shift in analyst sentiment highlights growing institutional interest in Mach’s Anadarko-focused oil and gas model and its acquisition-led growth approach. Next, we’ll explore how this wave of bullish analyst coverage could influence Mach Natural Resources’ existing investment narrative and...

Enerpac Tool Group Corp. recently reported past third-quarter 2026 results showing year-over-year growth in sales to US$167.55 million and net income to US$29.8 million, while also completing a US$80.44 million buyback of 2,078,645 shares announced in October 2025. The company also slightly refined its full-year 2026 net sales outlook to a US$635 million–US$645 million range, highlighting management’s focus on calibrating expectations alongside improving earnings per share. We’ll now examine...

TSMC (NYSE:TSM) has announced an additional US$100b investment in its Arizona fabrication facilities. The capital will be used to expand advanced chip production capacity in the U.S., with a focus on AI-focused semiconductors. This move deepens TSMC's role in U.S. manufacturing plans and the global build out of AI chip supply chains. Taiwan Semiconductor Manufacturing, the pure play foundry behind many leading edge chips, is further expanding its footprint in the U.S. with this new Arizona...

Earlier this month, regulators opened a Section 206 proceeding into PJM’s tariff rules for integrating large data-center loads, directly affecting New Era Energy & Digital’s data center and energy development plans in the region. By targeting how large, flexible and co-located loads pay for and access transmission upgrades, the review could materially influence New Era’s economics, grid access and long-term planning assumptions. We’ll now examine how PJM’s tariff review around integrating...

Kimbell Royalty Partners has delivered a 121.7% return over the past 5 years, yet its current valuation checks point to a stock that screens as overvalued on market multiples and only mixed on the broader metrics. That creates a clear tension for investors trying to weigh strong historical returns against what the current price implies. A 121.7% return over 5 years highlights that long term holders have already seen substantial gains, so the easy part of the rerating may be behind the...